zinc sulphate

ApprovedSmall molecule

IInternational Centre for Diarrhoeal Disease Research, Bangladesh

zinc sulphate is one of 96 small molecule programs targeting Bronchiolitis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BronchiolitisActive, not recruiting

PneumoniaActive, not recruiting

Acute DiarrheaActive, not recruiting

GrowthActive, not recruiting

BronchiolitisPhase 3

Active, not recruiting

PneumoniaPhase 3

Active, not recruiting

Acute DiarrheaPhase 2/Phase 3

Active, not recruiting

GrowthApproved

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

zinc sulphate

IInternational Centre for Diarrhoeal Disease Research, Bangladesh

Approved

1 2

Jakafi

Incyte

Preclinical

1 3

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 4

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

2 5

Pepcid

KKenvue Brands

Preclinical

1 6

Aciphex

Akero Therapeutics

Preclinical

1 7

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 8

Alka-Seltzer

AAbbott

Preclinical

1 9

Tylenol

KKenvue Brands

Preclinical

1 10

Prograf

VVeloxis Pharmaceuticals

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Effectiveness1 trial

EFFECTIVENESS of ZINC AS an ADJUVANT to STANDARD THERAPY VERSUS STANDARD THERAPY ALONE in CHILDREN

Completed·KKing Edward Medical University·Phase 3·NCT06869798·84 enrolled

Completed·CCentre For International Health·Phase 2/3·NCT00370968·352 enrolled

Growth1 trial

Effect of Zinc Supplementation on Appetite and Growth in Primary Malnourished Children

Unknown status·—·Phase 4·NCT03098810·50 enrolled

2 more indications

Immune Response1 trial

Studies of Immune Responses to Orally Administered Vaccines in Developing Country

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1/2·NCT01019083·1,016 enrolled

Diarrhea1 trial

Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea

Completed·—·N/A·NCT00682955·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for zinc sulphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — zinc sulphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for zinc sulphate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — International Centre for Diarrhoeal Disease Research, Bangladesh company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: IInternational Centre for Diarrhoeal Disease Research, Bangladesh

zinc sulphate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Effectiveness1 trial

Bronchiolitis1 trial

Pneumonia1 trial

Acute Diarrhea1 trial

Growth1 trial

Immune Response1 trial

Diarrhea1 trial

References

Drug Info

Quick Facts

Related News